Integrative Analysis Identified MCT4 as an Independent Prognostic Factor for Bladder Cancer

BackgroundBladder cancer is the 10th most common cancer and most common urothelial malignancy worldwide. Prognostic biomarkers for bladder cancer patients are required for individualized treatment. Monocarboxylate transporter 4 (MCT4), encoded by SLC16A3 gene, is a potential biomarker for bladder ca...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yang Zhao, Bin Zhao, Wei-Hua Yan, Yan Xia, Zhi-Hui Wang, Guo-Yang Zheng, Wen-Da Wang, Yu-Shi Zhang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2021-08-01
coleção:	Frontiers in Oncology
Assuntos:	bladder cancer monocarboxylate transporter 4 solute carrier family 16 member 3 single-cell RNA sequencing immunohistochemistry
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fonc.2021.704857/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!